Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
773.53-
QQQ
721.390.52%
BTC/USD
79764.711.8596%
DIA
536.520.08%
GLD
410.060.04%
TLT
82.400.4%

Anavex Life Sciences Corp

AVXLNASDAQ
Trade with Public
Trade with Public
$2.85
-0.04-1.38%
At close: Sep 2, 5:00 PM EST
$2.96
0.072.42%
Pre-Market: 8:20 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Anavex Life Sciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Anavex Life Sciences (AVXL).

Price Target Range — 10 Quarters

Analyst Consensus — 4 Analysts

3Buy
1Hold
Consensus RatingBuy# Analysts4Avg. Consensus PT$30Upside to Avg. PT+913.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Mar 31, 2026D. Boral CapitalJason KolbertMaintainedBuy$24
Mar 26, 2026D. Boral CapitalJason KolbertMaintainedBuy$24
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Anavex Life Sciences, Maintains $20 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $20 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Anavex Life Sciences, Maintains $24 Price Target

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $24 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Anavex Life Sciences, Maintains $24 Price Target

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $24 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Anavex Life Sciences, Maintains $24 Price Target

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $24 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Anavex Life Sciences, Maintains $24 Price Target

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $24 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Anavex Life Sciences, Maintains $20 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $20 price target.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved